TY  - GEN
AU  - Wang,Libing
AU  - Gao,Lei
AU  - Xu,Sheng
AU  - Gong,Shenglan
AU  - Liu,Min
AU  - Qiu,Huiying
AU  - Xu,Xiaoqian
AU  - Ni,Xiong
AU  - Chen,Li
AU  - Lu,Shuqing
AU  - Chen,Jie
AU  - Song,Xianmin
AU  - Zhang,Weiping
AU  - Yang,Jianmin
AU  - Hu,Xiaoxia
AU  - Wang,Jianmin
TI  - High prognostic value of minimal residual disease detected by flow-cytometry-enhanced fluorescence in situ hybridization in core-binding factor acute myeloid leukemia (CBF-AML)
SN  - 1432-0584
PY  - 2015///0218
KW  - ADP-ribosyl Cyclase 1
KW  - Adolescent
KW  - Adult
KW  - Antigens, CD34
KW  - analysis
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Cell Separation
KW  - methods
KW  - Chromosome Aberrations
KW  - Consolidation Chemotherapy
KW  - Core Binding Factor Alpha 2 Subunit
KW  - genetics
KW  - Cytarabine
KW  - Daunorubicin
KW  - Female
KW  - Flow Cytometry
KW  - Humans
KW  - In Situ Hybridization, Fluorescence
KW  - Kaplan-Meier Estimate
KW  - Leukemia, Myeloid, Acute
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Neoplasm, Residual
KW  - Neoplastic Stem Cells
KW  - chemistry
KW  - Oncogene Proteins, Fusion
KW  - Prognosis
KW  - RUNX1 Translocation Partner 1 Protein
KW  - Young Adult
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s00277-014-2107-z
ER  -